CD44 and breast carcinoma: In breast cancer, the CD44+/CD24−/low cells from patients were found to be more tumorigenic than the CD44+/CD24+ cells when implanted into the mammary fat pads of the immunodeficient nonobese diabetic (NOD)/severe combined immunodeficient (SCID) mice7.